Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,239,000 | 1,188,000 | 1,093,000 | 901,000 | 791,000 |
| Cost of Goods | 246,000 | 231,000 | 174,000 | 159,000 | 127,000 |
| Gross Profit | 994,000 | 957,000 | 919,000 | 742,000 | 664,000 |
| Operating Expenses | 731,000 | 919,000 | 1,077,000 | 827,000 | 451,000 |
| Operating Income | 262,000 | 38,000 | -156,000 | -85,000 | 213,000 |
| Interest Expense | 45,000 | 41,000 | 35,000 | 29,000 | 27,000 |
| Other Income | 22,000 | 23,000 | 42,000 | 19,000 | 4,000 |
| Pre-tax Income | 239,000 | 20,000 | -149,000 | -95,000 | 190,000 |
| Income Tax | 29,000 | 13,000 | -20,000 | -42,000 | -15,000 |
| Net Income Continuous | 210,000 | 7,000 | -129,000 | -53,000 | 205,000 |
| Net Income | $210,000 | $7,000 | $-129,000 | $-53,000 | $205,000 |
| EPS Basic Total Ops | 1.68 | 0.05 | -0.94 | -0.38 | 1.41 |
| EPS Basic Continuous Ops | 1.68 | 0.05 | -0.94 | -0.38 | 1.41 |
| EPS Diluted Total Ops | 1.64 | 0.05 | -0.94 | -0.38 | 1.35 |
| EPS Diluted Continuous Ops | 1.64 | 0.05 | -0.94 | -0.38 | 1.35 |
| EPS Diluted Before Non-Recurring Items | 2.50 | 1.66 | 1.57 | 1.16 | 0.90 |
| EBITDA(a) | $282,000 | $66,000 | $-143,000 | $-64,000 | $235,000 |